Wellysis has signed a strategic partnership agreement with Medicalgorithmics S.A., a Poland-based company specializing in AI-driven cardiac diagnostics.

This collaboration marks another important milestone for the global expansion of S-Patch, Wellysis’s flagship wearable ECG monitoring device.

Medicalgorithmics is widely recognized for its expertise in arrhythmia detection and ECG analysis, with a strong presence in both European and U.S. healthcare markets.

Through this partnership, Wellysis will integrate its FDA-cleared, lightweight wearable ECG device, S-Patch, with Medicalgorithmics’ advanced DeepRhythm Platform (DRP) and DeepRhythmAI (DRAI) algorithms. 

This collaboration will enable more precise, real-time analysis of patient data and is expected to enhance product capabilities and support global customer expansion.

It also represents a significant step forward in Wellysis’s mission to lead innovation in digital health and advance global cardiac monitoring.